Literature DB >> 31914881

LncRNA XIST serves as a ceRNA to regulate the expression of ASF1A, BRWD1M, and PFKFB2 in kidney transplant acute kidney injury via sponging hsa-miR-212-3p and hsa-miR-122-5p.

Qian Cheng1, Lin Wang2.   

Abstract

We aimed to identify potential mechanism associated with acute kidney injury (AKI) after kidney transplantation. The dataset GSE53771, which contained 18 zero-hour (ZERO group) and 18 selected post-transplant (POST group) biopsy samples from 18 kidney allografts (8 AKI and 10 controls) was downloaded from GEO database. Differentially expressed miRNAs (DEMIs) were screened using limma package, and bidirectional hierarchical clustering of the DEMIs was performed using the pheatmap package. Target genes of DEMIs were predicted by miRWalk 2.0, miRNA-target genes networks were presented using Cytoscape, protein-protein interaction (PPI) networks were constructed by STRING (version:10.0) database, and competing endogenous RNAs (ceRNA) regulating network were constructed using Cytoscape. In ZERO and POST groups, a total of 4 and 24 differentially expressed miRNAs were obtained in AKI samples compared with control, respectively. Specifically, 71 lncRNAs were obtained to interact with five miRNAs (hsa-miR-215-5p, hsa-miR-192-5p, hsa-miR-422a, hsa-miR-212-3p and hsa-miR-122-5p). Histone chaperone ASF1A (ASF1A) and bromodomain and WD repeat-containing protein 1(BRWD1) were targeted by hsa-miR-212-3p in PPI network. In ceRNA network, lncRNA XIST could interact with four miRNAs (hsa-miR-212-3p, hsa-miR-122-5p, hsa-miR-215-5p, and hsa-miR-192-5p). LncRNA XIST might serve as a ceRNA to sponge hsa-miR-212-3p to regulate the development of AKI via altering the expression of ASF1A/BRWD1. Furthermore, lncRNA XIST could also interact with hsa-miR-122-5p to modulate the expression of PFKFB2 in thyroid hormone signaling pathway and AMPK signaling pathway. LncRNA XIST can serve as a ceRNA to sponge hsa-miR-212-3p and hsa-miR-122-5p to regulate AKI progression via modulating the expression of ASF1A, BRWD1, and PFKFB2.[Figure: see text].

Entities:  

Keywords:  Acute kidney injury; competing endogenous RNAs; differentially expressed microRNAs; kidney transplantation; target genes

Mesh:

Substances:

Year:  2020        PMID: 31914881      PMCID: PMC7028162          DOI: 10.1080/15384101.2019.1707454

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  47 in total

Review 1.  Acute kidney injury in kidney transplantation.

Authors:  James E Cooper; Alexander C Wiseman
Journal:  Curr Opin Nephrol Hypertens       Date:  2013-11       Impact factor: 2.894

2.  Histone chaperone ASF1B promotes human β-cell proliferation via recruitment of histone H3.3.

Authors:  Pradyut K Paul; Mary E Rabaglia; Chen-Yu Wang; Donald S Stapleton; Ning Leng; Christina Kendziorski; Peter W Lewis; Mark P Keller; Alan D Attie
Journal:  Cell Cycle       Date:  2016-10-18       Impact factor: 4.534

3.  MiR-212-3p inhibits LPS-induced inflammatory response through targeting HMGB1 in murine macrophages.

Authors:  Weiwei Chen; Xiaoying Ma; Peng Zhang; Qifeng Li; Xin Liang; Jianwen Liu
Journal:  Exp Cell Res       Date:  2016-12-08       Impact factor: 3.905

4.  Natural RNA circles function as efficient microRNA sponges.

Authors:  Thomas B Hansen; Trine I Jensen; Bettina H Clausen; Jesper B Bramsen; Bente Finsen; Christian K Damgaard; Jørgen Kjems
Journal:  Nature       Date:  2013-02-27       Impact factor: 49.962

Review 5.  The cell cycle and acute kidney injury.

Authors:  Peter M Price; Robert L Safirstein; Judit Megyesi
Journal:  Kidney Int       Date:  2009-06-17       Impact factor: 10.612

6.  Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001.

Authors:  Jay L Xue; Frank Daniels; Robert A Star; Paul L Kimmel; Paul W Eggers; Bruce A Molitoris; Jonathan Himmelfarb; Allan J Collins
Journal:  J Am Soc Nephrol       Date:  2006-02-22       Impact factor: 10.121

Review 7.  Emerging biomarkers of acute kidney injury.

Authors:  Prasad Devarajan
Journal:  Contrib Nephrol       Date:  2007       Impact factor: 1.580

8.  Diagnostic and prognostic potential of differentially expressed miRNAs between metastatic and non-metastatic renal cell carcinoma at the time of nephrectomy.

Authors:  Zofia Wotschofsky; Jonas Busch; Monika Jung; Carsten Kempkensteffen; Steffen Weikert; Klaus D Schaser; Ingo Melcher; Ergin Kilic; Kurt Miller; Glen Kristiansen; Andreas Erbersdobler; Klaus Jung
Journal:  Clin Chim Acta       Date:  2012-11-21       Impact factor: 3.786

Review 9.  Acute Kidney Injury.

Authors:  Anna Zuk; Joseph V Bonventre
Journal:  Annu Rev Med       Date:  2016       Impact factor: 13.739

10.  starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data.

Authors:  Jun-Hao Li; Shun Liu; Hui Zhou; Liang-Hu Qu; Jian-Hua Yang
Journal:  Nucleic Acids Res       Date:  2013-12-01       Impact factor: 16.971

View more
  19 in total

1.  Dysregulated circular RNAs are closely linked to multiple myeloma prognosis, with circ_0026652 predicting bortezomib‑based treatment response and survival via the microRNA‑608‑mediated Wnt/β‑catenin pathway.

Authors:  Lu Li; Jin Liu; Juan Du; Hua Jiang; Haiyan He; Jing Lu; Wanting Qiang; Nan Hou; Pei Guo; Yan Zhuang; Weijun Fu
Journal:  Oncol Rep       Date:  2022-09-21       Impact factor: 4.136

2.  LncRNA Snhg1 Plays an Important Role via Sequestering rno-miR-139-5p to Function as a ceRNA in Acute Rejection After Rat Liver Transplantation Based on the Bioinformatics Analysis.

Authors:  Wu Wu; Menghao Wang; Chunming Li; Zhu Zhu; Yang Zhang; Di Wu; Zhibing Ou; Zuojin Liu
Journal:  Front Genet       Date:  2022-06-02       Impact factor: 4.772

3.  Osteosarcoma Cell-Derived Exosomal ELFN1-AS1 Mediates Macrophage M2 Polarization via Sponging miR-138-5p and miR-1291 to Promote the Tumorgenesis of Osteosarcoma.

Authors:  Bangmin Wang; Xin Wang; Po Li; Xiaoying Niu; Xiaoxiao Liang; Guancong Liu; Zhiyong Liu; Hong Ge
Journal:  Front Oncol       Date:  2022-06-17       Impact factor: 5.738

4.  ELK1‑mediated upregulation of lncRNA LBX2‑AS1 facilitates cell proliferation and invasion via regulating miR‑491‑5p/S100A11 axis in colorectal cancer.

Authors:  Gang Ma; Weijie Dai; Juan Zhang; Qianjun Li; Biao Gu; Yaqi Song; Xiaozhong Yang
Journal:  Int J Mol Med       Date:  2021-06-03       Impact factor: 4.101

5.  miR-21 protects against lipopolysaccharide-stimulated acute kidney injury and apoptosis by targeting CDK6.

Authors:  Wei Wei; Yuan-Yuan Yao; Hong-Yuan Bi; Zhe Zhai; Yan Gao
Journal:  Ann Transl Med       Date:  2020-03

Review 6.  Biological Function of Long Non-coding RNA (LncRNA) Xist.

Authors:  Wenlun Wang; Lu Min; Xinyuan Qiu; Xiaomin Wu; Chuanyang Liu; Jiaxin Ma; Dongyi Zhang; Lingyun Zhu
Journal:  Front Cell Dev Biol       Date:  2021-06-10

Review 7.  Crosstalk of lncRNA and Cellular Metabolism and Their Regulatory Mechanism in Cancer.

Authors:  Yang-Hsiang Lin
Journal:  Int J Mol Sci       Date:  2020-04-22       Impact factor: 5.923

8.  Integrated Genome-Wide Methylation and Expression Analyses Reveal Key Regulators in Osteosarcoma.

Authors:  Fei Wang; Guoqing Qin; Junzhi Liu; Xiunan Wang; Baoguo Ye
Journal:  Comput Math Methods Med       Date:  2020-08-13       Impact factor: 2.238

9.  Long non-coding RNA Xist regulates oocyte loss via suppressing miR-23b-3p/miR-29a-3p maturation and upregulating STX17 in perinatal mouse ovaries.

Authors:  Meng Zhou; Xiaoqiu Liu; E Qiukai; Yanxing Shang; Xiaoqian Zhang; Shuting Liu; Xuesen Zhang
Journal:  Cell Death Dis       Date:  2021-05-25       Impact factor: 8.469

10.  Integrative Analysis of HTNV Glycoprotein Derived MHC II Epitopes by In Silico Prediction and Experimental Validation.

Authors:  Hao Sun; Zhenhua Lu; Guoyun Xuan; Ning Liu; Tianhu Wang; Yang Liu; Mingfu Lan; Jiahao Xu; Yuancai Feng; Shuang Xu; Yuchen Lu; Baozeng Sun; Jinpeng Zhang; Xiyang Zhang; Yuanjie Sun; Shuya Yang; Yun Zhang; Yusi Zhang; Linfeng Cheng; Dongbo Jiang; Kun Yang
Journal:  Front Cell Infect Microbiol       Date:  2021-07-19       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.